Dergiler / Turkish Journal of Medical Sciences / 2021 / Cilt: 51 - Sayı: 5

Assessment of olfactory and gustatory functions in COVID-19 patients

Sayfa
2296–2303
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Objective tests may show that frequency of olfactory dysfunction is greater than frequency of self-reported olfactory dysfunction.Key words: COVID-19, anosmia, ageusia, sniffin sticks

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Background/aim: This study aims to evaluate of olfactory and gustatory functions of COVID-19 patients and possible risk factors for olfactory and gustatory dysfunctions.
📊
Temel Bulgular & Veri:Materials and methods: The cross-sectional study included adult patients who were diagnosed with COVID-19 in Gazi University Hospital between April 2020 and June 2020.
💡
Sonuç & Katkı:Objective tests may show that frequency of olfactory dysfunction is greater than frequency of self-reported olfactory dysfunction.Key words: COVID-19, anosmia, ageusia, sniffin sticks
🔬Tür:Uygulamalı Anket & Alan Araştırması
📍Kapsam:2020 Verileri
⚙️Değişkenler:Alan Parametreleri

Abstract

Background/aim: This study aims to evaluate of olfactory and gustatory functions of COVID-19 patients and possible risk factors for olfactory and gustatory dysfunctions. Materials and methods: The cross-sectional study included adult patients who were diagnosed with COVID-19 in Gazi University Hospital between April 2020 and June 2020. Volunteered patients participated in a survey in which olfactory and gustatory functions and various clinical information were questioned. Sinonasal Outcome Test-22 was also administrated to all patients. Results: A hundred and seventy-one patients participated in this study. Olfactory and gustatory dysfunctions rates were 10.5% (n: 18) and 10.5% (n: 18), respectively. Patients without any symptom other than smell and taste dysfunctions were clustered as group 1 and patients who are clinically symptomatic were clustered as group 2. Olfactory dysfunction occurred in 8% of group 1 and 17.4% of group 2 (p = 0.072). Gustatory dysfunction rate of smokers was 19.7% and significantly higher than gustatory dysfunction rate of nonsmokers (5.5%) (p = 0.007). Twenty-seven-point-eight percent of the patients with olfactory dysfunction (n = 5) were male and 72.2% (n: 13) were female. Sex did not show significant effect on rate of olfactory dysfunction. Twenty-five patients participated in psychophysical olfactory function test. No participant reported olfactory dysfunction at the time of test. Of the participants, 64% (n: 16) were normosmic and 36% (n: 9) were hyposmic according to Sniffin’ Stick test. Conclusion: Olfactory and gustatory dysfunctions are more common in patients who are clinically symptomatic than those diagnosed during contact tracing. Objective tests may show that frequency of olfactory dysfunction is greater than frequency of self-reported olfactory dysfunction.Key words: COVID-19, anosmia, ageusia, sniffin sticks

🔖

Bu Makaleye Atıf Yap

https://orcid.org/0000-0001-9112-3986, H., DÜZLÜ, M., CEYLAN, A., TUTAR, H., CEBECİ, S., ŞAHİN, M. M., DİZBAY, M., UZUNOĞLU, E., YALÇIN, M., CESUR, G., YILDIZ, M., ÖZGER, H. S., YILDIZ, P. A. (2022). Assessment of olfactory and gustatory functions in COVID-19 patients. Turkish Journal of Medical Sciences, Cilt: 51 - Sayı: 5, 2296–2303. https://ajindex.com/articles/609316

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (12)

  1. Guan W, Ni Z, Hu Y, Liang W, Ou C et al. Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine 2020
  2. 382 (18): 1708-1720. doi: 10.1056/NEJMoa2002032 2. Wang D, Hu B, Hu C, Zhu F, Liu X et al. Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus– Infected Pneumonia in Wuhan, China. JAMA 2020
  3. 323 (11): 1061-1069. doi: 10.1001/jama.2020.1585 3. Mao L, Jin H, Wang M, Hu Y, Chen S et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology 2020
  4. 77 (6):683-690. doi: 10.1001/jamaneurol.2020.1127 4. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. European Archives of Otorhinolaryngology 2020
  5. 277 (8):2251-2261. doi: 10.1007/s00405-020-05965-1 5. Vaira LA, Salzano G, Deiana G, De Riu G. Anosmia and Ageusia: Common Findings in COVID-19 Patients. Laryngoscope 2020
  6. 130 (7):1787. doi: 10.1002/lary.28692 6. Gane SB, Kelly C, Hopkins C. Isolated sudden onset anosmia in COVID-19 infection. A novel syndrome? Rhinology 2020
  7. 58 (3): 299-301. doi:10.4193/Rhin20.114 7. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M et al. Self-reported Olfactory and Taste Disorders in Patients With Severe Acute Respiratory Coronavirus 2 Infection: A Crosssectional Study. Clinical Infectious Diseases 2020
  8. 71 (15): 889- 890. doi: 10.1093/cid/ciaa330 8. Vaira LA, Deiana G, Fois AG, Pirina P, Madeddu G et al. Objective evaluation of anosmia and ageusia in COVID-19 patients: Single-center experience on 72 cases. Head and Neck 2020
  9. 42 (6): 1252-1258. doi: 10.1002/hed.26204 9. Welge-Lüssen A, Wolfensberger M. Olfactory disorders following upper respiratory tract infections. Advances in OtoRhino-Laryngology 2006
  10. doi: 10.1159/000093758 10. Suzuki M, Saito K, Min WP, Vladau C, Toida K et al. Identification of viruses in patients with postviral olfactory dysfunction. Laryngoscope 2007
  11. 117 (2): 272-277. doi: 10.1097/01.mlg.0000249922.37381.1e 11. van Riel D, Verdijk R, Kuiken T. The olfactory nerve: a shortcut for influenza and other viral diseases into the central nervous system. The Journal of Pathology 2015
  12. 235 (2): 277-287. doi: 10.1002/path.4461 12. Xu H, Zhong L, Deng J, Peng J, Dan H et al. High expression of ACE2 receptor of 2019-nCoV on the epithelial cells o